Cleared Traditional

K991618 - BI-O.K. SELF-CONTAINED BIOLOGICAL INDICATOR

K991618 is an FDA 510(k) clearance for BI-O.K. SELF-CONTAINED BIOLOGICAL INDICATOR, manufactured by Propper Mfg. Co., Inc.. The device is a Class 2 General Hospital device with product code FRC cleared through the Traditional 510(k) pathway after a 624-day FDA review.

K991618 · Propper Mfg. Co., Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2001
Decision
624d
Days
Class 2
Risk

K991618 is an FDA 510(k) clearance for the BI-O.K. SELF-CONTAINED BIOLOGICAL INDICATOR. Classified as Indicator, Biological Sterilization Process (product code FRC), Class II - Special Controls.

Submitted by Propper Mfg. Co., Inc. (Long Island, US). The FDA issued a Cleared decision on January 24, 2001 after a review of 624 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.2800 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Propper Mfg. Co., Inc. devices

FDA 510(k) Submission Details - K991618

510(k) Number K991618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 1999
Decision Date January 24, 2001
Days to Decision 624 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
495d slower than avg
Panel avg: 129d · This submission: 624d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FRC Device Classification - Class 2, Special Controls

Product Code FRC Indicator, Biological Sterilization Process
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRC Indicator, Biological Sterilization Process

All 131
Devices cleared under the same product code (FRC) and FDA review panel - the closest regulatory comparables to K991618.
SPSMEDICAL SPORVIEW STEAM BI TEST PACK
K022706 · Spsmedical Supply Corp. · Oct 2002
3M ATTEST 290 AUTO-READER
K004009 · 3M Company · Mar 2002
STERRAD CYCLESURE BIOLOGICAL INDICATOR
K994055 · Advanced Sterilization Products · Feb 2002
STERRAD BI TEST PACK
K993775 · Advanced Sterilization Products · Jun 2000
MODIFICATION OF: STERRAD BI TEST PACK
K991675 · Advanced Sterilization Products · Jun 1999
STERITEC DISPOSABLE BIOLOGICAL TEST PACK-EO GAS
K981497 · Steritec Products Mfg Co, Inc. · Oct 1998